Seeking Alpha11hAutomated tone · neutral
Moderna rallies despite bearish views ahead of cancer vaccine dataInvesting.com3dAutomated tone · neutral
Moderna technical outlook: bullish trend meets near-term pullbackSeeking Alpha4dAutomated tone · neutral
Notable healthcare headlines for the week: Novavax, Moderna and Becton Dickinson in focusSeeking Alpha6dAutomated tone · bullish
Moderna gains 14% to set fresh 52-week highSeeking Alpha9dAutomated tone · neutral
Novavax, Moderna cool as WHO downplays plague-related death in RussiaSeeking Alpha11dAutomated tone · neutral
SA Asks: Is Moderna's stock now a sell after the recent run-up?Seeking Alpha12dAutomated tone · bullish
Moderna, Illumina lead healthcare gains in September as medtech dragsSeeking Alpha12dAutomated tone · neutral
Notable analyst calls this week: Target, Moderna and PepsiCo among top picksSeeking Alpha14dAutomated tone · neutral
Moderna to join Nasdaq-100, replacing Warner Bros. DiscoveryInvesting.com14dAutomated tone · neutral
Moderna to replace Warner Bros Discovery on Nasdaq 100Seeking Alpha15dAutomated tone · bearish
Moderna slips as Citi cuts to Sell on “unjustifiable” valuationMarketWatch15dAutomated tone · bullish
Citi tells investors it’s time to sell Moderna after 600%-plus stock gainsSeeking Alpha17dAutomated tone · bearish
Pfizer, BioNTech, Moderna dealt blow in effort to dismiss mRNA patent lawsuitsSeeking Alpha24dAutomated tone · bullish
Moderna rallies 12% to set new highMarketWatch24dAutomated tone · neutral
Moderna will reveal the data for its mRNA cancer vaccine next month. Here’s why it matters.Yahoo Finance24dAutomated tone · bullish
Moderna (MRNA) Soars to Fresh High Ahead of Pipeline Updates This WeekFortune24dAutomated tone · neutral
Moderna’s Bob Langer and AI pioneer Yann LeCun join board of Cellular Intelligence, bringing AI into medicine via a Parkinson’s drugYahoo Finance26dAutomated tone · bullish
Dow Jones Futures Rise; Can The Market Take Flight? Robinhood, Sandisk, AMD, Moderna Surge Into Buy AreasYahoo Finance33dAutomated tone · neutral
Dow Jones Futures: Fed Rate Hike Seen As Oil, Yields Pressure Stocks; Apple, Moderna Are New BuysYahoo Finance34dAutomated tone · bullish
How Cathie Wood's Fund Gave Us A Back Door To Moderna's BreakthroughSeeking Alpha34dAutomated tone · bullish
Moderna climbs 8% as volatile trading continuesYahoo Finance38dAutomated tone · neutral
How Is Moderna's Stock Performance Compared to Other Healthcare StocksSeeking Alpha39dAutomated tone · neutral
Notable healthcare headlines for the week: UnitedHealth, Moderna, and Medtronic in focusSeeking Alpha40dAutomated tone · neutral
Healthcare August recap: Moderna jumps 156% as biotech shines; DaVita sinksYahoo Finance42dAutomated tone · neutral
BioNTech vs. Moderna: Which Is the Better Cancer Vaccine Stock to Buy Now?Seeking Alpha42dAutomated tone · bullish
Moderna slips as Rothschild issues rare Sell rating after cancer vaccine-led rallyYahoo Finance42dAutomated tone · neutral
Moderna’s Cancer Vaccine Rally Sparks Rare Sell Rating and Projected 44% Stock DropYahoo Finance42dAutomated tone · neutral
This Fund Bought Moderna Before It Nearly Tripled. See Its 2 New Stock PicksMarketWatch45dAutomated tone · bullish
23 best-performing stocks of August, as the software industry continues its recoveryYahoo Finance46dAutomated tone · neutral
Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results EncouragingYahoo Finance46dAutomated tone · neutral
Healthcare’s Best Week Since June Traces Back to a Single Moderna and Merck Cancer TrialInvesting.com48dAutomated tone · bullish
Success after a century of failures: Inside Moderna and Merck’s cancer vaccine breakthroughSeeking Alpha48dAutomated tone · bearish
Arcturus, Moderna fall after BioNTech's cancer vaccine setbackYahoo Finance48dAutomated tone · neutral
Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks?Seeking Alpha48dAutomated tone · neutral
Moderna prices upsized $2.6B offering of convertible senior notesYahoo Finance49dAutomated tone · bullish
Tempus AI (TEM) Jumped on Moderna’s Melanoma Win. Did its $1.5B Personalis Acquisition Just Get Validated?Yahoo Finance49dAutomated tone · neutral
BioNTech (BNTX) Rallied on Moderna’s Win. Does a Competitor’s Success Validate its Oncology Pipeline?Seeking Alpha49dAutomated tone · neutral
Moderna announces proposed private placement of $2B of convertible senior notesFortune50dAutomated tone · neutral
Dolly Parton once gave $1 million to help develop the Moderna COVID vaccine at Vanderbilt: ‘I’m kind of addicted to the feeling of giving’Yahoo Finance51dAutomated tone · bullish
Wolfe Research Just Upgraded Moderna Stock. Here's Why.Seeking Alpha51dAutomated tone · bullish
Moderna extends gains as Wolfe upgrades on trial win for cancer therapySeeking Alpha52dAutomated tone · neutral
Biotech Breakout: What's in focus after Moderna's cancer win?Seeking Alpha53dAutomated tone · neutral
Notable healthcare headlines for the week: Moderna, Merck, and Twist Bioscience in focusInvesting.com55dAutomated tone · bullish
Moderna cancer vaccine breakthrough revives hopes for biotech turnaroundYahoo Finance55dAutomated tone · neutral
Moderna Stock Is Just The Start: Why AI-Focused Money Might Flow Into BiotechYahoo Finance55dAutomated tone · bullish
Stock Market Rally Buckles; Moderna, Gold, Bitcoin Surge While Walmart Tumbles: Weekly ReviewInvesting.com55dAutomated tone · bullish
Why is Moderna stock rallying today?MarketWatch56dAutomated tone · bullish
Moderna’s personalized mRNA shot could reshape the fight against skin cancer — but it may also be overhypedInvesting.com56dAutomated tone · neutral
Walmart, Moderna among market cap stock movers on ThursdayInvesting.com56dAutomated tone · neutral
Why is Moderna stock plummeting today?Investing.com56dAutomated tone · neutral
SpaceX, Moderna among market cap stock movers on ThursdayInvesting.com56dAutomated tone · bullish
Moderna stock pulls back after massive one-day rally: analysts weigh inYahoo Finance56dAutomated tone · bullish
After Moderna stock surge of 177% on cancer drug breakthrough, here's what Wall Street thinks happens nextNew York Times Business56dAutomated tone · neutral
Moderna’s Shift to Cancer Company Lifts Stock Up 177%Seeking Alpha56dAutomated tone · bullish
Moderna breakthrough: The options lottery tickets that paid outSeeking Alpha56dAutomated tone · neutral
Trump’s Moderna bet gets a double doseSeeking Alpha56dAutomated tone · bullish
Moderna nearly triples in record S&P 500 move, but analyst sees more volatility aheadInvesting.com57dAutomated tone · neutral
Morgan Stanley raises Moderna stock price target to $89 on platform strengthMarketWatch57dAutomated tone · bullish
Moderna’s cancer-vaccine breakthrough drives broad biopharma stock rallySeeking Alpha57dAutomated tone · bullish
Biotechs hit a post-pandemic high after mRNA trial win for Moderna, MerckInvesting.com57dAutomated tone · bullish
BofA upgrades Moderna stock rating on cancer drug progressInvesting.com57dAutomated tone · neutral
Moderna, Estee Lauder among market cap stock movers on WednesdayInvesting.com57dAutomated tone · bullish
Moderna is surging today: is it a short or momentum play?Seeking Alpha57dAutomated tone · neutral
Moderna shorts reportedly suffer $5B loss after stock’s sudden riseInvesting.com57dAutomated tone · bullish
Why is Moderna stock surging today?Yahoo Finance57dAutomated tone · neutral
Moderna shares double as cancer vaccine data rekindles investor hopesSeeking Alpha57dAutomated tone · bullish
BioNTech’s rally on Moderna trial win likely to fade, Leerink saysInvesting.com57dAutomated tone · bullish
Moderna short sellers face $4.8 billion loss amid record stock jumpSeeking Alpha57dAutomated tone · bullish
Moderna surges on trial win for cancer shot; William Blair upgradesCNBC57dAutomated tone · bullish
Jim Cramer's top 10 things to watch in the stock market WednesdayMarketWatch57dAutomated tone · bullish
Moderna’s experimental vaccine prevents cancer recurrence, in ‘historic’ win for personalized medicine. Its stock soared.Seeking Alpha57dAutomated tone · bullish
Moderna, Merck rise after late-stage trial win for mRNA cancer therapyInvesting.com57dAutomated tone · bullish
Vaccine stocks jump on Moderna’s melanoma vaccine trial resultsCNBC57dAutomated tone · bullish
Cancer vaccine from Moderna, Merck shows promise in late-stage trial; both stocks soarInvesting.com59dAutomated tone · neutral
Moderna CEO Stephane Bancel sells $28.7m in sharesInvesting.com70dAutomated tone · bullish
Why did Moderna stock reverse gains and close lower today?Yahoo Finance70dAutomated tone · bullish
Moderna Wavers Despite Hard-Fought FDA Win; Will Its Sprint Restart?Investing.com70dAutomated tone · bullish
Why is Moderna stock rallying today?New York Times Business71dAutomated tone · neutral
F.D.A. Approves Moderna’s mRNA Flu VaccineSeeking Alpha72dAutomated tone · bullish
Moderna rises after starting phase 1 trial of Ebola vaccineSeeking Alpha75dAutomated tone · neutral
July healthcare recap: Regeneron, DexCom shine as Moderna, managed-care stocks retreatSeeking Alpha76dAutomated tone · bullish
Moderna reiterates up to 10% 2026 revenue growth while lowering cash cost guidance to ~$4BYahoo Finance76dAutomated tone · bullish
Moderna Q2 Earnings Call HighlightsInvesting.com76dAutomated tone · neutral
Earnings call transcript: Moderna Q2 2026 loss narrows as stock rises premarketInvesting.com76dAutomated tone · neutral
Why is Moderna stock sliding today?Seeking Alpha76dAutomated tone · neutral
Earnings Snapshot: Moderna sees 55% of H2 revenue in Q3, reiterates 2026 growth target as norovirus trial misses early metricYahoo Finance78dAutomated tone · neutral
Moderna Stock Has Doubled in 2026, But Wall Street Still Isn’t ConvincedYahoo Finance79dAutomated tone · bullish
2 Major Reasons to Buy Moderna Stock Before July 31